WELS:XETRA:XETRA-Amundi S&P Global Health Care ESG UCITS ETF DR EUR Acc (EUR)

ETF | Others |

Last Closing

USD 11.512

Change

+0.08 (+0.66)%

Market Cap

USD 0.25B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

ETFs Containing WELS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.99% 74% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.99% 74% C 73% C
Trailing 12 Months  
Capital Gain 17.61% 65% D 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.61% 65% D 66% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.95% 43% F 43% F
Dividend Return 1.95% 42% F 41% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.59% 86% B+ 89% A-
Risk Adjusted Return 42.55% 59% D- 61% D-
Market Capitalization 0.25B 54% F 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.